Philip Morris International Inc. News
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HBLENDS, EETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, SENTIA, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 73 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
see morePhilip Morris International Inc. Market News
05 May at 14:42
Philip Morris Q1 Beat FDA Delays Pressure PM Drop!
- Philip Morris reported a stronger-than-expected Q1 with solid smoke‑free growth and reaffirmed full‑year guidance, but FDA review delays for nicotine‑pouch products and notable insider selling weighed on PM stock, causing a near 5% pullback. The company maintains a steady dividend and a dual revenue engine of high‑margin smoke‑free offerings plus cigarette pricing power.
28 Apr at 14:42
PM Stock Falls on FDA Delay, Japan Tax Headwinds!!
Philip Morris (PM) slid nearly 5% after reports of FDA slowdowns on nicotine-pouch approvals and fresh Japan tobacco taxes. Despite short-term technical weakness and regulatory pressure, analyst ratings remain largely positive with meaningful upside in price targets. Investors should monitor approval timelines, regional tax developments, and upcoming earnings for clarity.
21 Apr at 14:41
Philip Morris Q1 Gains; Japan Tax Headwinds, PM Q2
Recent concrete developments — a white paper that pressured shares, solid Q1 2026 revenue and heated-tobacco growth, and scheduled Japanese excise-tax hikes — create measurable near-term headwinds for Philip Morris (PM) while underscoring the company’s long-term smoke-free transition.
14 Apr at 14:42
PM Stock Slumps After FDA Delays ZYN Ultra Rollout
Philip Morris shares plunged after the FDA delayed approval of ZYN Ultra, triggering a one-day drop near 6% and amplifying concerns about the company’s smoke-free growth trajectory. Analysts remain cautiously optimistic, but near-term regulatory and competitive pressures have increased investor scrutiny.
24 Feb at 14:46
Philip Morris: Smoke-Free Gains, Japan Tax Risk
Philip Morris reported strong smoke-free growth—EPS up double digits and smoke-free products now over 41% of revenue—but near-term headwinds from Japan excise hikes and ZYN inventory normalization could pressure PM stock in the S&P 500.
17 Feb at 14:32
Philip Morris PM: Smoke-Free Growth vs BAT's Velo!
Philip Morris reported strong smoke-free revenue and margin expansion while British American Tobacco's Velo posted a sharp U.S. sales surge. Elevated trading volumes and recent guidance make PM stock sensitive to competitive and regulatory catalysts — here are the key facts and investor takeaways from the past week.
